Literature DB >> 1615267

Role and extent of lymphadenectomy for early breast cancer.

D S Robinson1, G M Senofsky, A S Ketcham.   

Abstract

A better understanding of the locoregional and systemic approaches to breast cancer over the past decade and one-half has altered the perspective on surgical management of the axilla. An increased awareness of the importance of early diagnosis and appropriate staging has focused further attention on the extent of resection of axillary lymph nodes. Examined here are the anatomy and physiology of the axillary lymph nodes, their clinical evaluation, the significance of histologic evaluation, a discussion of the procedure's role in staging and therapy, and a presentation of the complications of axillary lymph node dissection. It is in this light that we discuss the extent of axillary lymphadenectomy in early diagnosis of breast cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1615267     DOI: 10.1002/ssu.2980080206

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  4 in total

1.  Breast cancer metastasis and the lymphatic system.

Authors:  Munazzah Rahman; Sulma Mohammed
Journal:  Oncol Lett       Date:  2015-07-13       Impact factor: 2.967

2.  What modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?

Authors:  R Arisio; A Sapino; P Cassoni; G Accinelli; M C Cuccorese; M P Mano; G Bussolati
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

3.  Breast Cancer Sentinel Node Detection: An Alternative Solution for Centers Lacking Nuclear Technology.

Authors:  Mahmoud A Alhussini; Ahmed T Awad; Mohamed H Ashour; Ahmed Abdelateef; Haytham Fayed
Journal:  Breast Care (Basel)       Date:  2016-08-15       Impact factor: 2.860

4.  A predictive index of axillary nodal involvement in operable breast cancer.

Authors:  M De Laurentiis; C Gallo; S De Placido; F Perrone; G Pettinato; G Petrella; C Carlomagno; L Panico; P Delrio; A R Bianco
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.